Steven M. Larson
19Patents
7h-index
49Co-inventors
66Inventor score
Filing activity: Nov 27, 1984 → Jul 5, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6451995B1 | Single chain FV polynucleotide or peptide constructs of anti-ganglioside GD2 antibodies, cells expressing same and related methods | Chemistry; Metallurgy | 89 | Expired |
| US4775759A | Synthesis and utilization of 17-methyl and 17-cyclopropylmethyl-3,14-dihydroxy-4,5.alpha.-epoxy 6.beta.-fluoromorphinans (foxy and cyclofoxy) as (18F)-labeled opioid ligands for position emission transaxial tomography (PETT) | Human Necessities | 23 | Expired |
| US9625456B2 | Fluorescent silica-based nanoparticles | Emerging Cross-Sectional Technologies | 16 | Active |
| US10548998B2 | Multimodal silica-based nanoparticles | Physics | 13 | Active |
| US10548997B2 | Fluorescent silica-based nanoparticles | Emerging Cross-Sectional Technologies | 9 | Active |
| US10039847B2 | Multimodal silica-based nanoparticles | Physics | 9 | Active |
| US9999694B2 | Multimodal silica-based nanoparticles | Physics | 9 | Active |
| US10167285B2 | Small-molecule HSP90 inhibitors | Physics | 4 | Active |
| US11419955B2 | Multimodal silica-based nanoparticles | Physics | 3 | Active |
| US5185142A | Antigen-specific composition and in vivo methods for detecting and localizing an antigenic site and for radiotherapy | Human Necessities | 2 | Expired |
| US10676476B2 | Small-molecule HSP90 inhibitors | Chemistry; Metallurgy | 1 | Active |
| US10988534B2 | Multi-specific antibodies with affinity for human A33 antigen and DOTA metal complex and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US10806808B2 | Systems and methods for determining optimum patient-specific antibody dose for tumor targeting | Chemistry; Metallurgy | 0 | Active |
| US12161734B2 | Multimodal silica-based nanoparticles | Physics | 0 | Active |
| US11858993B2 | Multi-specific antibodies with affinity for human A33 antigen and DOTA metal complex and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11607465B2 | Uses of labeled HSP90 inhibitors | Physics | 0 | Active |
| US11565005B2 | Dota-hapten compositions for anti-dota/anti-tumor antigen bispecific antibody pretargeted radioimmunotherapy | Chemistry; Metallurgy | 0 | Active |
| US12195554B2 | Anti-polysialic acid antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11633502B2 | Bone marrow-, reticuloendothelial system-, and/or lymph node-targeted radiolabeled liposomes and methods of their diagnostic and therapeutic use | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.